Clinical trial
Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and…
NCT00074750 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00074750 |
|---|---|
| Title | Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) |
| Official title | A Phase I Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Wake Forest University |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia |
| Intervention type | Drug |
| Interventions | DTGM |
| Enrollment | 7 |
| Start date | Dec 1, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Dec 23, 2003 |
| Last update posted | Feb 22, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: